| Título: | A Comparison in Cosmetic Results of Cobalt 60 and Photon 9 Mega Volt for the Whole Breast Radiotherapy in Breast Cancer Patients with Breast Conserving Surgery |
| Autores: |
Babazade, Sh; Breast Cancer Study Group, Isfahan University of Medical Sciences, Isfahan, Iran Emami, H; School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran Amouheidari, AR; Breast Cancer Study Group, Isfahan University of Medical Sciences, Isfahan, Iran Roayaei, M; Breast Cancer Study Group, Isfahan University of Medical Sciences, Isfahan, Iran Hassanzade, A; School of Public health, Isfahan University of Medical Sciences, Isfahan, Iran Akbari, A; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran |
| Fecha: | 2011-09-20 |
| Publicador: | Shahid Beheshti University of Medical Sciences |
| Fuente: |
Ver documento |
| Tipo: |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| Tema: | Breast neoplasm; Breast conserving surgery; Adjuvant radiotherapy; Cosmetic effect |
| Descripción: | Background: To compare the cosmetic results of whole breast radiotherapy between cobalt 60 and photon 9MegaVolt in patients underwent breast conserving surgery.Methods: The patients with breast saving surgery who were treated by whole breast radiotherapy with either cobalt 60 or photon 9MV between 2001-2006 in Sayed-al-Shohada hospital entered the study. The cosmetic results were evaluated by an expert radiation oncologist with definite criteria.Results: Frothy patients in cobalt 60 group and 43 patients in photon group were compared, with median follow up of 40.5 months. The patients in photon group had less telangectasia and discoloration (p=0.018 and p=0.01, respectively). The consistency of breast in photon group was better (p=0.019), but for fibrosis the difference was not statistically significant (p=0.055).Overall cosmetic results in photon group was much better rather than cobalt 60 group (p=0.005). No recurrences were observed in both groups.Conclusion: Cosmetic results in group with photon 9MV were superior to cobalt group, but the effect of these two beam energy on disease free survival (DFS) and /or overall survival (OS) should be in more consideration.Keywords: Breast neoplasm; Breast conserving surgery; Adjuvant radiotherapy; Cosmetic effectReferences1. Akbari ME. Iran Cancer Report. Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran: Darolfekr; 2008.2. Budrukkar AN, Sarin R, Shrivastava SK, Deshpande DD, Dinshaw KA. Cosmesis, late sequelae and local control after breast-conserving therapy: influence of type of tumour bed boost and adjuvant chemotherapy. Clin Oncol (R Coll Radiol) 2007; 19(8):596-603.3. Wang HT, Barone CM, Steigelman MB, Kahlenberg M, Rousseau D, Berger J, et al. Aesthetic outcomes in breast conservation therapy. Aesthet Surg J 2008; 28(2):165-70.4. Akbari ME, Khayamzadeh M, Khoshnevis SJ, Nafissi N, Akbari A. Five and Ten years Survival in Breast Cancer Patients Mastectomies vs Breast Conserving Surgeries personal Experience. Iran J Cancer Prev.2008; 1(2):53-6.5. Poortmans P. Evidence based radiation oncology: breast cancer. Radiother Oncol 2007; 84(1):84-101.6. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347(16):1233-41.7. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366(9503):2087-2106.8. Sneeuw KC, Aaronson NK, Yarnold JR, Broderick M, Regan J, Ross G, et al. Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 2. Relationship with psychosocial functioning. Radiother Oncol 1992; 25(3):160-6.9. Al Ghazal SK, Fallowfield L, Blamey RW. Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity? Eur J Surg Oncol 1999; 25(6):571-3.10. Al Ghazal SK, Fallowfield L, Blamey RW. Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur J Cancer 2000; 36(15):1938-43.11. Rose MA, Olivotto I, Cady B, Koufman C, Osteen R, Silver B, et al. Conservative surgery and radiation therapy for early breast cancer. Long-term cosmetic results. Arch Surg 1989; 124(2):153-7.12. Cardoso MJ, Cardoso J, Santos AC, Vrieling C, Christie D, Liljegren G, et al. Factors determining esthetic outcome after breast cancer conservative treatment. Breast J 2007; 13(2):140-6.13. Cetintas SK, Ozkan L, Kurt M, Saran A, Tasdelen I, Tolunay S, et al. Factors influencing cosmetic results after breast conserving management (Turkish experience). Breast 2002; 11(1):72-80.14. Rochefordiere A, Abner AL, Silver B, Vicini F, Recht A, Harris JR. Are cosmetic results following conservative surgery and radiation therapy for early breast cancer dependent on technique? Int J Radiat Oncol Biol Phys 1992; 23(5):925-31.15. Deutsch M, Flickinger JC. Patient characteristics and treatment factors affecting cosmesis following lumpectomy and breast irradiation. Am J Clin Oncol 2003; 26(4):350-3.16. Maessen D, Flentje M, Weischedel U. [Cosmetic results of breast conserving therapy for breast carcinoma. Treatment results from the Heidelberg Radiation Clinic in the years 1984 to 1992]. Strahlenther Onkol 1998; 174(5):251-6.17. Olivotto IA, Rose MA, Osteen RT, Love S, Cady B, Silver B, et al. Late cosmetic outcome after conservative surgery and radiotherapy: analysis of causes of cosmetic failure. Int J Radiat Oncol Biol Phys 1989; 17(4):747-53.18. Palazzi M, Tomatis S, Valli MC, Guzzetti R, Tonoli S, Bertoni F, et al. Impact of radiotherapy technique on the outcome of early breast cancer treated with conservative surgery: A multicenter observational study on 1,176 patients. Int J Radiat Oncol Biol Phys 2006; 65(5):1361-7.19. Sarin R, Dinshaw KA, Shrivastava SK, Sharma V, Deore SM. Therapeutic factors influencing the cosmetic outcome and late complications in the conservative management of early breast cancer. Int J Radiat Oncol Biol Phys 1993; 27(2):285-92.20. Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JH, Jager JJ, et al. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol 2000; 55(3):219-32.21. Wazer DE, DiPetrillo T, Schmidt-Ullrich R, Weld L, Smith TJ, Marchant DJ, et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1992; 10(3):356-63.22. Collette S, Collette L, Budiharto T, Horiot JC, Poortmans PM, Struikmans H, et al. Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'. Eur J Cancer 2008; 44(17):2587-99.23. Bese NS, Munshi A, Budrukkar A, Elzawawy A, Perez CA. Breast radiation therapy guideline implementation in low- and middle-income countries. Cancer 2008; 113(8 Suppl):2305-14.24. Arenas M, Sabater S, Hernandez V, Henriquez I, Ameijide A, Anglada L, et al. Cosmetic outcome of breast conservative treatment for early stage breast cancer. Clin Transl Oncol 2006; 8(5):334-8.25. Al Ghazal SK, Blamey RW, Stewart J, Morgan AA. The cosmetic outcome in early breast cancer treated with breast conservation. Eur J Surg Oncol 1999; 25(6):566-70.26. Bayerl A, Frank D, Lenz A, Hoss C, Lukas P, Feldmann HJ, et al. Local tumor control and cosmetic outcome following breast-conserving surgery and radiation up to a total dose of 56 Gy without boost in breast cancer. Strahlenther Onkol 2001; 177(1):25-32.27. Halyard MY, Grado GL, Schomberg PJ, Weaver AL, Grant CS, Pisansky TM. Conservative therapy of breast cancer. The Mayo Clinic experience. Am J Clin Oncol 1996; 19(5):445-50.28. Hoeller U, Kuhlmey A, Bajrovic A, Grader K, Berger J, Tribius S, et al. Cosmesis from the patient's and the doctor's view. Int J Radiat Oncol Biol Phys 2003; 57(2):345-54.29. Al Ghazal SK, Fallowfield L, Blamey RW. Patient evaluation of cosmetic outcome after conserving surgery for treatment of primary breast cancer. Eur J Surg Oncol 1999; 25(4):344-6.30. Cardoso MJ, Santos AC, Cardoso J, Barros H, Cardoso DO. Choosing observers for evaluation of aesthetic results in breast cancer conservative treatment. Int J Radiat Oncol Biol Phys 2005; 61(3):879-81. |
| Idioma: | Inglés |
1 Health and Education - 2 por Akbari, Mohammad Esmaeil | 6 Effectiveness of Mindfulness-Based Cognitive Therapy on Reduction of Depression and Anxiety Symptoms in Mothers of Children With Cancer por Mehranfar, Mojtaba; Dept. of Counselling, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran,Younesi, Jalal; Dept. of Counselling, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran,Banihashem, Abdollah; Dept. of Internal Medicine and Paediatrics, University of
Medical Sciences, Mashhad, Iran |
2 The Study of DNA Methylation of bax Gene Promoter in Breast and Colorectal Carcinoma Cell Lines por Alipour, Mohsen; Dept. of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran,Zargar, Seyed Jalal; Dept. of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran,Safarian, Shahrokh; Dept. of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran,Fouladdel, Shamile; Dept. of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran,Azizi, Ebrahim; Dept. of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
Biotechnology Research Center, Tehran University of Medical Sciences, Tehran, Iran,Jafargholizadeh, Naser; Dept. of Cell & Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran | 7 Prevention and Management of Mucositis in Patients With Cancer: a Review Article por [wlia, ّatemeh; Dept. of Oral Medicine, Yazd Shahid Sadoughi University of Medical Sciences, Yazd, Iran,«azemeini, ُeidkazem; Burn hospital, Yazd Shahid Sadoughi University of Medical Sciences, Yazd, Iran,gholami, neda; Dept. of Oral Medicine, Yazd Shahid Sadoughi University of Medical Sciences, Yazd, Iran |
3 Cancer Prevention; Cancer Risk Management por Akbari, Mohammad Esmaeil | 8 Psychosocial Care for Breast Cancer: Physicians' Perspective por Kaviani, Ahmad; Department of surgery, Tehran University of Medical Sciences, Tehran, Iran,Mehrdad, N; Iranian Center for Breast Cancer (ICBC), Academic Center for Education, Culture and Research (ACECR), Tehran, Iran,Yunesian, M; school of Public Health , Environmental Research Center, Tehran University of Medical Sciences, Tehran, Iran,Shakiba, B; Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran,Ebrahimi, M; Iranian Center for Breast Cancer (ICBC), Academic Center for Education, Culture and Research (ACECR), Tehran, Iran,Majidzadeh, K; Iranian Center for Breast Cancer (ICBC), Academic Center for Education, Culture and Research (ACECR), Tehran, Iran,Akbari, ME; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran |
4 Euthanasia in Cancer Patients, Islamic Point of View por Mousavi, SM; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran,Akbari, A; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran,Akbari, ME; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran,Najd Sepas, H; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran | 9 Cell Survival Entropy and Cellular Resistance Activation Dose: Effect of Calprotectin on Gastric Adenocarcinoma Cell Line por Rezaei-Tavirani, Mostafa,Rahmati-Roodsari, Mohammad,Mirzaie, Mehdi,Amini Geram, Pooneh,Sobhi, Sara |
5 Evaluation of Prognostic Factors In Patients with Metastatic Breast Cancer por Saeidi Saedi, H,Seilanian Toosi, M,Mirsadraei, M,Roodbari, S | 10 Antiphospholipid Antibodies in Neoplastic Patients por Mortazavizadeh, MR,Sadeghmanesh, R |